文献速递母胎医学产科

产前测序在胎儿结构异常中的诊断率:系统综述更新

Diagnostic Yield of Sequencing for Prenatal Diagnosis of Fetal Structural Anomalies: An Updated Systematic Review.
PubMed 文献 · Prenat Diagn · 2026-03-02

本更新系统综述纳入155篇文献,评估产前测序在胎儿结构异常中较染色体微阵列分析(CMA)的额外诊断率。总体合并额外诊断率为27%(95%CI 24%-30%,p<0.0001),选择性、非选择性和探索性队列分别为40%、20%和17%。测序数据同步CNV分析较序贯测序多提供9例诊断。

要点

  • 胎儿结构异常且CMA阴性后,产前测序总体额外诊断率为27%。
  • 经仔细病例选择,额外诊断率可提高至40%。
  • 测序数据同步CNV分析较序贯测序多9例诊断。

核心结论

  • 产前测序在CMA阴性胎儿结构异常中提供27%的额外诊断率,仔细选择病例可增至40%。

研究设计与样本

  • 对选择性、非选择性和探索性队列及表型亚组进行亚组分析。

主要发现

  • 总体合并额外诊断率为27%(95%CI 24%-30%,p<0.0001)。
  • 选择性、非选择性和探索性亚组的诊断率分别为40%、20%和17%。
  • 测序数据同步CNV分析较CMA阴性后序贯测序多提供9例诊断。

临床怎么用

  • 对CMA阴性的胎儿结构异常,可考虑产前测序以提高诊断率。
  • 仔细选择病例可使额外诊断率提高至40%。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The clinical utility of sequencing in prenatal diagnosis is known, but diagnostic yield varies widely depending on clinical indication. Here we update an earlier systematic review reporting the diagnostic yield of prenatal sequencing in structurally abnormal fetuses, with particular focus on factors affecting diagnostic yield. The search strategy outlined in the previous review (2018-2022) was repeated to include reports published between October 2021 and January 2025. Combining these records with those from the earlier review, an overall incremental diagnostic yield of sequencing compared to chromosomal microarray analysis (CMA) was calculated and pooled in a meta-analysis. Subgroup analyses were performed on selected, unselected, and exploratory cohorts, as well as individual phenotypic subgroups. 155 records were reviewed (89 from the current and 66 from the earlier publication). The overall pooled diagnostic yield of sequencing above CMA across all indications was 27% (95% CI 24%-30%, p < 0.0001). Subgroup analysis showed that the diagnostic yield was 40%, 20%, and 17% in selected, unselected, and exploratory subgroups, respectively. Concurrent CNV analysis of sequencing data provided nine additional diagnoses over sequential sequencing after a non-diagnostic CMA. Prenatal sequencing provides an additional yield of 27% following a non-diagnostic CMA across a range of fetal structural anomalies, and this increases to 40% with careful case-selection. Sequencing continues to be a powerful diagnostic tool when performed for well-evidenced indications.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Lim KMX, Gibbs A, Scotchman E, et al. Diagnostic Yield of Sequencing for Prenatal Diagnosis of Fetal Structural Anomalies: An Updated Systematic Review. Prenat Diagn. 2026. PMID: 41772942. doi:10.1002/pd.70112

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。